Slide 1: FY26 Audited Full Year Results
ASX Announcement – 28 August 2026 Visionflex Group Limited (ASX:VFX) FY26 Audited Full Year Results Highlights: • Revenue of $4.2m, down 10% on pcp, reflecting customer requested deferral of hardware deliveries into FY27 • Positive operating cash flow in 2H FY26 • Net operating cash outflow improved
Slide 2: About Visionflex Group
ASX Announcement – 28 August 2026 Visionflex Group Limited (ASX:VFX) About Visionflex Group At Visionflex, we believe that healthcare should be accessible, efficient, and connected. Our integrated hardware and software platform allows healthcare providers to deliver comprehensive, collaborative care
Slide 3: FY26 Results Investor Presentation
ASX:VFX FY26 Results Investor Presentation 28 AUGUST 2026
Slide 4: The Visionflex mission
The Visionflex mission Empowering health practitioners globally with cutting edge technologies to elevate patient outcomes. Visionflex proprietary software and hardware connect a range of third-party medical devices to empower practitioners to deliver world class virtual care. FY26 RESULTS INVESTOR
Slide 5: Hardware
Hardware Visionflex hardware enables health practitioners to virtually conduct medical examinations with confidence and serves as a foundational step for establishing long term software subscriptions. PERIPHERALS + SOFTWARE DEVICE + PERIPHERALS + SOFTWARE MEDICAL CART + PERIPHERALS + SOFTWARE Mobile
Slide 6: Proprietary Software (Virtual Care Platform)
Proprietary Software (Virtual Care Platform) A clinically capable comprehensive virtual healthcare platform empowering practitioners to virtually examine, diagnose, monitor and treat patients remotely. Perform collaborative, clinical, evidence-based A user-friendly video conferencing platform that d
Slide 7: FY26 Highlights
FY26 Highlights FY26 RESULTS INVESTOR PRESENTATION / AUGUST 2026 / 5
Slide 8: FY26 Financial Summary
FY26 Financial Summary Disciplined cost management and a higher margin revenue mix drove a material reduction in the underlying loss and a return to positive operating cash flow in the second half. Visionflex revenue Subscription revenue Gross margin Underlying EBITDA 2 Annual Recurring Revenue (Sof
Slide 9: Key Customer Wins – FY26
Key Customer Wins – FY26 Visionflex continued to broaden its enterprise and government customer base across FY26. Secured a statewide Partnership with Amplar Health Strategic Partnership with New contracts with Royal Flying contract with NSW Health to (Medibank) continued to scale Aspen Medical whic
Slide 10: Key Customer Wins – FY26
Key Customer Wins – FY26 Broadening enterprise, government and international pipeline. US EXPANSION INDIGENOUS HEALTH REGIONAL PHN’s BlueCare Queensland renewed New contracts secured Expanded footprint in New contracts secured with 26 facilities during the year, through distribution partners Indigen
Slide 11: Unattended Access Capability
ASX:VFX PRODUCT INNOVATION Unattended Access Capability FY26 RESULTS INVESTOR PRESENTATION / AUGUST 2026 / 9
Slide 12: Product Innovation – Unattended Access Capability
Product Innovation – Unattended Access Capability A new product category enabling virtual care in settings where staffing a local operator has not been practical. 1 2 3 Clinician leads the Live control of clinical examination devices No trained operator required consultation remotely via the Visionf
Slide 13: FY26 Financial Overview
FY26 Financial Overview FY26 RESULTS INVESTOR PRESENTATION / AUGUST 2026 / 11
Slide 14: Financial Dashboard
Financial Dashboard Multi-year trend of margin quality improvement and recurring revenue growth. Revenue Revenue (by type) (by region) ARR Underlying Growth EBITDA FY26 RESULTS INVESTOR PRESENTATION / AUGUST 2026 / 12
Slide 15: Profit & Loss
Profit & Loss A higher margin revenue mix and cost discipline drove a material narrowing in underlying losses, and the Group enters FY27 with a materially lower cost base. 1 Software and support revenue grew 27% to $1.7m and represented 41% of Group PROFIT AND LOSS – 30 JUNE Y/E ($000) FY26 FY25 % V
Slide 16: Balance Sheet
Balance Sheet A materially strengthened balance sheet supports the Group's continued transition toward sustained cash generation. BALANCE SHEET – 30 JUNE Y/E ($000) FY26 FY25 % VAR Cash and cash equivalents 1,622 1,890 (14%) 1 Net liabilities reduced from $1.8m to $0.015m over the year, following th
Slide 17: Cash Flow Statement
Cash Flow Statement Operating cash flow turned positive in 2H FY26, with long term stability supported by recurring software revenue. CASH FLOW STATEMENT – 30 JUNE Y/E ($000) FY26 FY25 % VAR 1 Positive operating cash flow was achieved in 2H FY26, the first positive half-year Receipts from customers
Slide 18: FY27 Outlook
FY27 Outlook FY26 RESULTS INVESTOR PRESENTATION / AUGUST 2026 / 16
Slide 19: Outlook – FY27 & Beyond
Outlook – FY27 & Beyond We enter FY27 with a materially lower cost base, improved cash generation and a growing pipeline of enterprise opportunities. Our priorities are to: Grow recurring revenue within the installed base, expanding site counts with existing enterprise customers and converting deplo
Slide 20: Important notices
Important notices This results presentation (Presentation) has been prepared by Visionflex Group Limited ACN 138 897 533 (ASX:VFX) (Company) and is dated 28 August 2026. A number of figures, amounts, percentages, estimates, calculations of values and fractions in this Presentation are subject to the
Slide 21: Joshua Mundey
CONTACT Joshua Mundey MANAGING DIRECTOR & CEO jmundey@visionflex.com VISIONFLEX GROUP LIMITED Unit 1, 8 Prosperity Parade Warriewood NSW 2102 VFX-GROUP.COM FY26 RESULTS INVESTOR PRESENTATION / AUGUST 2026 / 19